DIACOMIT is the only FDA-approved antiseizure medication specifically for seizures associated with Dravet syndrome in children as young as 6 months. It is indicated for patients weighing 15 pounds or more and taking clobazam.
550 Hills Drive
Suite 200B
Bedminster, NJ 07921
To report suspected adverse reactions, contact Biocodex at 866-330-3050
or FDA at 800-FDA-1088 or www.fda.gov/medwatch.
Biocodex is a family-owned pharmaceutical company that offers health solutions to patients in more than 120 countries through our own operations or long-term partnerships. At Biocodex, we listen to the needs of patients, caregivers, and healthcare professionals to develop innovative products and solutions. We are dedicated to advancing scientific research and using our expertise to benefit the rare disease community.
Learn more about Biocodex, Inc
Please see Accessing DIACOMIT for details. For further help navigating insurance coverage or cost challenges, please call Biocodex By Your Side at 833-248-0467 (Monday–Friday, 8:00 am to 8:00 pm Eastern time).
